Clinical Data leads drug stocks north
January 24, 2011 at 11:27 AM EST
Clinical Data shares are soaring in early trading on news that the FDA has approved its new psychiatric drug, Viibryd.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.